Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
203 Leser
Artikel bewerten:
(1)

Amplity Health Appoints Kevin Murphy as New Head of Account Development

Appointment comes during accelerating growth of Amplity's leading global medical and commercial franchise

LANGHORNE, PA / ACCESSWIRE / September 28, 2023 / Amplity Health (Amplity), a leading global contract medical and commercial partner to biopharmaceutical companies, today announced the appointment of Kevin Murphy as Senior Vice President of Account Development.

Amplity Appoints Kevin Murphy as New Head of Account Development

Amplity Appoints Kevin Murphy as New Head of Account Development
Appointment comes during accelerating growth of Amplity's leading global medical and commercial franchise

Kevin has a proven track record in developing and implementing mutually beneficial strategic partnerships with life science clients hungry for commercial growth. As a senior commercial leader, Kevin has led biopharmaceutical teams from the pre-commercial clinical stage through loss of exclusivity in over 25 branded products. His experience on the manufacturer side will enrich Amplity's ability to address the needs of clients no matter their corporate timing in lifecycle management.

Leveraging that experience, Kevin will lead Amplity's strategy and approach to establishing driving organic growth through his approach of mutual benefit to both client and provider. He will lead an account development team of tenured professionals across Amplity's global businesses of Commercial Solutions, Medical Solutions, Learning Solutions, Access Solutions, Consultative Services, and Insights Solutions.

"Kevin's professional background makes him ideally suited to lead the commercial organization," explained Michael A. Griffith, Amplity President and CEO. "He will help us execute our plans to accelerate growth and become a multi-brand organization focused on in-licensing, partnering, and commercializing products worldwide."

Kevin has 25+ years of broad commercial executive experience across the pharmaceutical, vaccines, medical device, and biotech industries. Most recently, Kevin was the General Manager of Vaccines at Sanofi, where he was globally responsible for pediatrics. He has also worked as Head of Contracting & Business Development for Bayer Healthcare, leading their US contract strategy and client engagement for multiple brands. At both Sanofi and Bayer, Kevin's businesses exceeded all financial expectations by double-digit percentages year over year through his innovative customer engagement strategies.

"I am inspired by Amplity's mission to challenge the boundaries of medical and commercial strategies," said Kevin. "I am excited to be able to offer Amplity's integrated Medical, Medical Communications, and Commercial Solutions to accelerate the approval and launch of new drugs to improve the lives of patients."

Follow Amplity on Twitter and LinkedIn to stay informed.

About Amplity Health

Amplity Health is a global contract medical and commercial organization, bringing over 40 years of experience from best-in-class organizations merged under the Amplity name. Amplity delivers tailored medical and commercial solutions that scale throughout the lifecycle of a drug. Amplity is a global authority in scientific stakeholder engagement, go-to-market strategies, and is built upon their belief in the power of face-to-face interaction that nurtures trust with physicians, patients, and payers, allowing for the exchange of complex ideas. Amplity's core strengths include their proprietary network of stakeholders, influencers, and decision makers; a foundation of qualitative insights and actionable data that informs every solution they craft and execute; and their deep expertise/focus on oncology and specialty therapies.

For more information, visit amplity.com. Amplity Health is a portfolio company of Altamont Capital Partners.

Contact Information

Gwen Coverdale
Press Relations
gwen.coverdale@amplity.com

SOURCE: Amplity Health

.

View source version on accesswire.com:
https://www.accesswire.com/787874/amplity-health-appoints-kevin-murphy-as-new-head-of-account-development

© 2023 ACCESS Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.